Corner Therapeutics - About the company
Corner Therapeutics is a series B company based in Watertown (United States), founded in 2019 by Jeffrey Karp, Jonathan Kagan and Jeff Karp. It operates as a Developer of immuno-therapeutics to treat cancer. Corner Therapeutics has raised $75.3M in funding. The company has 3360 active competitors, including 1144 funded and 800 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of immuno-therapeutics to treat cancer. It offers a proprietary chemical mimic called dendritic cell hyperactivation, which stimulates protective immunity through the production of polyclonal populations of long-lived memory T cells.
- Website
- cornertx.com
- Social
- Email ID
- *****@cornertx.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2019
Location
Watertown, United States
Stage
Series B
Total Funding
$75.3M in 2 rounds
Latest Funding Round
Investors
Ranked
137th among 3360 active competitors
Employee Count
27 as on Jul 31, 2026
Similar Companies
Legal entities associated with Corner Therapeutics
Corner Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CORNER THERAPEUTICS, INC. CIN: 843148800 , United States, Active | Dec 31, 1999 | - | 32 (As on Dec 31, 2024) | - |
Sign up to download Corner Therapeutics' company profile
Corner Therapeutics's funding and investors
Corner Therapeutics has raised a total funding of $75.3M over 2 rounds. Its first funding round was on Apr 18, 2024. Corner Therapeutics has 4 institutional investors.
Here is the list of recent funding rounds of Corner Therapeutics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 26, 2025 | 7087834 | Series B | 4299885 | 6046715 | 8352280 | 2263289 |
Apr 18, 2024 | 5526866 | Series A | 4085883 | 2678573 | 9276495 |
Access funding benchmarks and valuations. Sign up today!View details of Corner Therapeutics's funding rounds and investors
Corner Therapeutics' founders and board of directors
Founder? Claim ProfileHere are the details of Corner Therapeutics' key team members:
- Jeffrey Karp: Co-Founder of Corner Therapeutics and founder of 5 other companies, including Alivio Therapeutics, Landsdowne Labs and Frequency Therapeutics.
- Jonathan Kagan: Co-Founder & President of Corner Therapeutics.
- Jeff Karp: Co-Founder of Corner Therapeutics and founder of 1 other company. Contact Info: 1 email address
View details of Corner Therapeutics's Founder profiles and Board Members
Corner Therapeutics' employee count trend
Corner Therapeutics has 27 employees as of Jul 26. Here is Corner Therapeutics's employee count trend over the years:
Uncover Corner Therapeutics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Corner Therapeutics's Competitors and alternates
Top competitors of Corner Therapeutics include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Corner Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 80/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 73/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 71/100 | |
9th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
137th | Corner Therapeutics 2019, Watertown (United States), Series B | Developer of immuno-therapeutics to treat cancer | $75.3M | 61/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Corner Therapeutics's competitors? Click here to see the top ones
Corner Therapeutics's Investments and acquisitions
Corner Therapeutics has made no investments or acquisitions yet.
Reports related to Corner Therapeutics
Here is the latest report on Corner Therapeutics's sector:
News related to Corner Therapeutics
Media has covered Corner Therapeutics for a total of 3 events in the last 1 year, 1 of them has been about company updates and 1 about people movement.
•
•
Corner Therapeutics Appoints Biotech Pioneer John Maraganore as Strategic AdviserBusiness Wire•Sep 18, 2025•Corner Therapeutics
•
•
Corner Therapeutics to Present Data on mRNA Immunotherapies at FOCiS 2025Business Wire•Jun 24, 2025•Corner Therapeutics
•
•
•
•
Corner Therapeutics Appoints Rick Malley, M.D., to Serve on Scientific Advisory BoardBusiness Wire•Apr 25, 2023•Corner Therapeutics
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Corner Therapeutics
Explore our recently published companies
- Bernierobbins - Unfunded company
- Baronhats - United States based, Unfunded company
- Nivmeh - 2023 founded, Unfunded company
- eldoLED - United States based, 2005 founded, Unfunded company
- Right E-Waste Recycle - Unfunded company
- Connect Info Solutions - Mumbai based, 2012 founded, Unfunded company
